Matthew Pauls, Director at SOLENO THERAPEUTICS INC (SLNO), sold 11,874 shares at $71.55 ($850K) on 2025-03-28, disclosed to the SEC on 2025-03-31.
Open-market sale of $850k SLNO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.55 | 5,937 | $425K | 50.0% |
| 2 | $71.55 | 5,937 | $425K | 50.0% |
| Total | $71.55 avg | 11,874 | $850K | 100% |
| Filing → |
| SVRA | SELL | 2024-12-16 | $362K | — | Filing → |
| SVRA | SELL | 2023-12-29 | $396K | — | Filing → |
| SVRA | BUY | 2021-12-08 | $7K | — | Filing → |